7/1/21 17:43 | 6/30/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S | -4,125 | 165.00 | 0 | -25 | -4 | 573 | D | | | | | | | | | | | | | | |
6/30/21 17:33 | 6/28/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S | -3,914 | 156.55 | 0 | -25 | -4 | 598 | D | | | | | | | | | | | | | | |
6/23/21 17:54 | 6/21/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S | -3,215 | 128.62 | 0 | -25 | -4 | 623 | D | | | | | | | | | | | | | | |
12/2/20 16:26 | 11/30/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | M.d | 1,422 | 14.22 | 0 | 100 | 18 | 648 | D | | | | | | | | | | | | | | |
12/2/20 16:26 | 11/30/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.d | -12,500 | 125.00 | 0 | -100 | -13 | 648 | D | | | | | | | | | | | | | | |
10/13/20 16:44 | 10/8/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | M.dm | 361 | 14.43 | 0 | 25 | 4 | 648 | D | | | | | | | | | | | | | | |
10/13/20 16:44 | 10/8/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.dm | -2,500 | 100.00 | 0 | -25 | -4 | 648 | D | | | | | | | | | | | | | | |
9/3/20 16:44 | 9/1/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | M.d | 359 | 14.36 | 0 | 25 | 4 | 648 | D | | | | | | | | | | | | | | |
9/3/20 16:44 | 9/1/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.d | -2,316 | 92.62 | 0 | -25 | -4 | 648 | D | | | | | | | | | | | | | | |
8/21/20 16:11 | 8/19/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | M.d | 350 | 14.00 | 0 | 25 | 4 | 648 | D | | | | | | | | | | | | | | |
8/21/20 16:11 | 8/19/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.d | -2,500 | 100.00 | 0 | -25 | -4 | 648 | D | | | | | | | | | | | | | | |
7/9/20 16:00 | 7/7/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | M.d | 282 | 11.28 | 0 | 25 | 4 | 648 | D | | | | | | | | | | | | | | |
7/9/20 16:00 | 7/7/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.d | -2,250 | 90.00 | 0 | -25 | -4 | 648 | D | | | | | | | | | | | | | | |
7/6/20 16:14 | 7/1/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S | -4,000 | 80.00 | 0 | -50 | -7 | 648 | D | | | | | | | | | | | | | | |
6/25/20 16:28 | 6/23/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S | -3,750 | 75.00 | 0 | -50 | -7 | 698 | D | | | | | | | | | | | | | | |
5/27/20 16:34 | 5/22/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.m | -3,510 | 70.20 | 0 | -50 | -6 | 748 | D | | | | | | | | | | | | | | |
5/21/20 16:37 | 5/19/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S | -3,250 | 65.00 | 0 | -50 | -6 | 798 | D | | | | | | | | | | | | | | |
11/21/19 16:09 | 11/19/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | M.d | 485 | 14.43 | 0 | 34 | | 0 | D | | | | | | | | | | | | | | |
11/21/19 16:09 | 11/19/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | MA | DO | P | S.d | -2,353 | 70.00 | 0 | -34 | -100 | 0 | D | | | | | | | | | | | | | | |
7/12/19 16:10 | 7/10/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | S | -2,500 | 50.00 | 0 | -50 | -6 | 848 | D | | | | | | | | | | | | | | |
6/12/19 16:16 | 6/10/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | S | -2,250 | 45.00 | 0 | -50 | -5 | 898 | D | | | | | | | | | | | | | | |
3/5/19 17:59 | 3/1/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | S.m | -3,443 | 40.40 | 0 | -85 | -8 | 948 | D | | | | | | | | | | | | | | |
2/27/19 16:10 | 2/25/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | S | -591 | 40.00 | 0 | -15 | -1 | 1,033 | D | | | | | | | | | | | | | | |
1/10/19 16:09 | 1/8/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | S.m | -3,502 | 35.02 | 0 | -100 | -9 | 1,048 | D | | | | | | | | | | | | | | |
5/21/18 16:54 | 5/17/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | M.d | 620 | 8.27 | 0 | 75 | 7 | 1,148 | D | | | | | | | | | | | | | | |
5/21/18 16:54 | 5/17/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | P | S.d | -4,500 | 60.00 | 0 | -75 | -6 | 1,148 | D | | | | | | | | | | | | | | |
9/5/17 18:33 | 8/31/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -383 | 20.76 | 0 | -18 | -2 | 1,148 | D | | | | | | | | | | | | | | |
9/5/17 18:33 | 9/5/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.d | 7 | 1.81 | 0 | 4 | 0 | 1,148 | D | | | | | | | | | | | | | | |
8/30/17 18:36 | 8/28/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.dm | 42 | 1.81 | 0 | 23 | 2 | 1,163 | D | | | | | | | | | | | | | | |
8/30/17 18:36 | 8/28/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -1,535 | 20.25 | 0 | -76 | -6 | 1,163 | D | | | | | | | | | | | | | | |
6/23/17 16:20 | 6/22/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.d | 20 | 1.81 | 0 | 11 | 1 | 1,215 | D | | | | | | | | | | | | | | |
6/23/17 16:20 | 6/22/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.d | -166 | 15.37 | 0 | -11 | -1 | 1,215 | D | | | | | | | | | | | | | | |
6/21/17 17:42 | 6/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.dm | 55 | 1.81 | 0 | 30 | 3 | 1,215 | D | | | | | | | | | | | | | | |
6/21/17 17:42 | 6/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -454 | 15.01 | 0 | -30 | -2 | 1,215 | D | | | | | | | | | | | | | | |
6/12/17 17:02 | 6/8/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.dm | 10 | 1.81 | 0 | 5 | 0 | 1,215 | D | | | | | | | | | | | | | | |
6/12/17 17:02 | 6/8/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -80 | 15.02 | 0 | -5 | 0 | 1,215 | D | | | | | | | | | | | | | | |
6/1/17 17:25 | 5/30/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.d | 7 | 1.81 | 0 | 4 | 0 | 1,215 | D | | | | | | | | | | | | | | |
6/1/17 17:25 | 5/30/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.d | -55 | 15.02 | 0 | -4 | 0 | 1,215 | D | | | | | | | | | | | | | | |
5/18/17 18:43 | 5/16/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.dm | 91 | 1.81 | 1 | 50 | 4 | 1,215 | D | | | 4 | 13 | -22 | 3 | 5 | 0 | | | | | | |
5/18/17 18:43 | 5/16/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -813 | 16.26 | 1 | -50 | -4 | 1,215 | D | | | 4 | 13 | -22 | 3 | 5 | 0 | | | | | | |
5/9/17 17:28 | 5/5/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.d | 1 | 1.81 | 1 | 1 | 0 | 1,215 | D | | | 9 | 6 | -8 | -13 | -2 | 3 | 0 | | | | | |
5/9/17 17:28 | 5/5/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.d | -10 | 16.92 | 1 | -1 | 0 | 1,215 | D | | | 9 | 6 | -8 | -13 | -2 | 3 | 0 | | | | | |
5/4/17 17:44 | 5/2/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.dm | 89 | 1.81 | 1 | 49 | 4 | 1,215 | D | | | -11 | -6 | -13 | -14 | -2 | -5 | 2 | 2 | | | | |
5/4/17 17:44 | 5/2/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -805 | 16.30 | 1 | -49 | -4 | 1,215 | D | | | -11 | -6 | -13 | -14 | -2 | -5 | 2 | 2 | | | | |
4/21/17 16:35 | 4/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | M.dm | 91 | 1.81 | 1 | 50 | 4 | 1,215 | D | | | | -18 | -19 | -17 | -8 | -13 | -2 | 0 | | | | |
4/21/17 16:35 | 4/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Novak Rodger | V8 | DO | CEO | S.dm | -894 | 17.88 | 1 | -50 | -4 | 1,215 | D | | | | -18 | -19 | -17 | -8 | -13 | -2 | 0 | | | | |